{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:45:53Z","timestamp":1761489953479},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152811","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T17:36:46Z","timestamp":1459532206000},"page":"e0152811","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine"],"prefix":"10.1371","volume":"11","author":[{"given":"Monika","family":"Simmons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Putnak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCC.0b013e3181e911a7","article-title":"Dengue hemorrhagic fever and shock syndromes","volume":"12","author":"S Ranjit","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"SB Halstead","year":"2003","journal-title":"Adv Virus Res"},{"issue":"42","key":"ref3","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"B Guy","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"BA Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/v3101800","article-title":"Next-generation dengue vaccines: novel strategies currently under development","volume":"3","author":"AP Durbin","year":"2011","journal-title":"Viruses"},{"issue":"42","key":"ref6","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1016\/j.vaccine.2011.07.017","article-title":"Next generation dengue vaccines: a review of candidates in preclinical development","volume":"29","author":"J Schmitz","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1586\/erv.10.159","article-title":"Unique challenges faced by the clinical evaluation of dengue vaccines","volume":"10","author":"R Edelman","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jiq060","article-title":"The necessity and quandaries of dengue vaccine development","volume":"203","author":"SJ Thomas","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1371\/journal.pntd.0000975","article-title":"Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand","volume":"5","author":"TP Endy","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"33","key":"ref10","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","article-title":"Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study","volume":"27","author":"A Kaltenbock","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/infdis\/174.6.1176","article-title":"Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys","volume":"174","author":"R Putnak","year":"1996","journal-title":"J Infect Dis"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.10.023","article-title":"Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy","volume":"396","author":"M Simmons","year":"2010","journal-title":"Virology"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4269\/ajtmh.14-0268","article-title":"An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques","volume":"92","author":"S Fernandez","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"19","key":"ref14","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00284-06","article-title":"Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques","volume":"80","author":"M Simmons","year":"2006","journal-title":"J Virol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.trstmh.2005.05.003","article-title":"The problem with dengue","volume":"99","author":"JR Stephenson","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1128\/JVI.67.10.6285-6288.1993","article-title":"Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone","volume":"67","author":"I Kurane","year":"1993","journal-title":"J Virol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/JVI.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"B Falgout","year":"1991","journal-title":"J Virol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/JVI.67.4.2034-2042.1993","article-title":"Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity","volume":"67","author":"B Falgout","year":"1993","journal-title":"J Virol"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1128\/JVI.79.9.5665-5675.2005","article-title":"Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections","volume":"79","author":"CP Simmons","year":"2005","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.vaccine.2006.10.035","article-title":"Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins","volume":"25","author":"LG Haller AA","year":"2007","journal-title":"Vaccine"},{"issue":"Pt 6","key":"ref21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1099\/vir.0.79896-0","article-title":"Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes","volume":"85","author":"X Jiao","year":"2004","journal-title":"J Gen Virol"},{"issue":"26","key":"ref22","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1016\/j.vaccine.2006.04.004","article-title":"HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4+ Th1 cell responses in vivo","volume":"24","author":"M Gao","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"ref23","doi-asserted-by":"crossref","first-page":"P59","DOI":"10.1186\/1475-2859-5-S1-P59","article-title":"Evaluation of the baculovirus and E. coli-expressed non-structural (NS) proteins of bluetongue virus (BTV) as antigen in an indirect or competition ELISA to differentiate infected from vaccinated animals","volume":"5","author":"L L\u00f3pez","year":"2006","journal-title":"Microbial Cell Factories"},{"issue":"21","key":"ref24","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.vaccine.2004.01.048","article-title":"Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice","volume":"22","author":"T W\u00fcest","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4269\/ajtmh.2001.65.420","article-title":"Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine","volume":"65","author":"M Simmons","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.99.2.291","article-title":"Dengue virus identification by the plaque reduction neutralization test","volume":"99","author":"PK Russell","year":"1967","journal-title":"J Immunol"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.63.6.2853-2856.1989","article-title":"Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis","volume":"63","author":"M Bray","year":"1989","journal-title":"J Virol"},{"key":"ref28","article-title":"Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection","author":"B Kaufman","year":"1989","journal-title":"DTIC Document"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/JVI.64.9.4356-4363.1990","article-title":"Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis","volume":"64","author":"B Falgout","year":"1990","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","article-title":"Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1","volume":"68","author":"JJ Schlesinger","year":"1987","journal-title":"J Gen Virol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/JVI.62.8.3027-3031.1988","article-title":"Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis","volume":"62","author":"YM Zhang","year":"1988","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00678.x","article-title":"Understanding the contribution of cellular immunity to dengue disease pathogenesis","volume":"225","author":"A Mathew","year":"2008","journal-title":"Immunol Rev"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1172\/JCI21512","article-title":"Dengue: defining protective versus pathologic immunity","volume":"113","author":"AL Rothman","year":"2004","journal-title":"J Clin Invest"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00069-07","article-title":"Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia","volume":"14","author":"R Appanna","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"SS Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/JVI.73.1.398-403.1999","article-title":"Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype","volume":"73","author":"AC Spaulding","year":"1999","journal-title":"J Virol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/CDLI.7.5.856-857.2000","article-title":"Human dengue antibodies against structural and nonstructural proteins","volume":"7","author":"K Vald\u00e9s","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4269\/ajtmh.1991.44.481","article-title":"Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever","volume":"44","author":"V Churdboonchart","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"25","key":"ref39","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"E Konishi","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/vim.1999.12.277","article-title":"Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge","volume":"12","author":"OV Morozova","year":"1999","journal-title":"Viral Immunol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1051\/vetres:2005049","article-title":"Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo","volume":"37","author":"H Rau","year":"2006","journal-title":"Vet Res"},{"key":"ref42","first-page":"2012","article-title":"Expression, purification, and evaluation of diagnostic potential and immunogenicity of a recombinant NS3 protein from all serotypes of dengue virus","author":"LM \u00c1lvarez-Rodr\u00edguez","year":"2012","journal-title":"J Trop Med"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11262-014-1087-3","article-title":"Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design","volume":"49","author":"R Ram\u00edrez","year":"2014","journal-title":"Virus Genes"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e25685","DOI":"10.1371\/journal.pone.0025685","article-title":"Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines","volume":"6","author":"SM Costa","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guerin DeltaureC::hly vaccine's superior protection against tuberculosis","volume":"210","author":"A Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"issue":"24","key":"ref46","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"EM Sitati","year":"2006","journal-title":"J Virol"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","article-title":"West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection","volume":"181","author":"JD Brien","year":"2008","journal-title":"The Journal of Immunology"},{"key":"ref48","article-title":"Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Infection","author":"L Rivino","year":"2012","journal-title":"J Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:39:17Z","timestamp":1692275957000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152811"}},"subtitle":[],"editor":[{"given":"Xia","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152811","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}